Clinical Trials Logo

Clinical Trial Summary

ERCP is the primary choice for removal of common bile duct stone (CBDS) currently. However, 4-24% patients underwent recurrence after successful clearance of CBDS. Stone re-formation due to chronic inflammation of biliary duct is generally considered an important cause of CBDS recurrence, which is associated with duodenal-biliary reflux (DBR) after sphincterotomy. Although it was believed that DBR was the important cause of CBDS recurrence, the direct evidence was still lacking. Here we conducted a case control study to investigate the DBR rate in patients with recurrent CBDS after ERCP.


Clinical Trial Description

n/a


Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02329977
Study type Observational
Source Fourth Military Medical University
Contact
Status Completed
Phase N/A
Start date June 2013
Completion date January 2014

See also
  Status Clinical Trial Phase
Completed NCT01190332 - Conventional Versus Rendezvous Technique of Intraoperative Endoscopic Retrograde Cholangiopancreatography N/A
Recruiting NCT02703077 - Endoscopic Treatment of Difficult Bile Duct Stones: Spyglass + EHL x Balloon Dilation of the Papilla Phase 4
Recruiting NCT01425177 - Effect of Saline Irrigation to DEcrease Rate Of Residual Common Bile Duct Stones Phase 3
Completed NCT01189734 - Comparison Between Laparoscopic Common Bile Duct Exploration and Intraoperative ERCP for Management of Common Bile Duct Stones N/A